From wnaiyds@eckmann.net  Sun Apr 24 08:26:37 2005
Return-Path: <wnaiyds@eckmann.net>
Received: from ODAP-62-0-82-84.bb.netvision.net.il (ODAP-62-0-82-84.bb.netvision.net.il [62.0.82.84])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3ODQBWQ030615;
	Sun, 24 Apr 2005 08:26:23 -0500
Received: from fencingroom.com ([218.145.68.166])
          by reid.frankrossphotographic.com
          (InterMail vK.4.04.00.00 371-192-985 license 9qz337kl1554w3pj8f7par9783f6xsm7)
          with ESMTP id <20035346170271.FOPT3910.boxcar@fencingroom.com>
          for <cypherpunks@al-qaeda.net>; Thu, 24 Mar 2005 09:15:42 -0500
Date: Thu, 24 Mar 2005 12:18:42 -0200
From: "Shanna Lord" <wnaiyds@eckmann.net>
Subject: Hot stocks for quick surge
X-Originating-IP: [204.140.239.1]
To: <cypherpunks@al-qaeda.net>
Message-ID: <588858571929.DQG53813@inconsistent.frankrossphotographic.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.1065.91)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: catheter@fencingroom.com
X-StarScan-Version: 5.7.04; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;cypherpunks@al-qaeda.net
Status: O
Content-Length: 3439
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,OO0,000 EST
Current Price: O.1O
2OO4 Success |ead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Paclitaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary 
metabo|ites of plants that include more than 2,OOO different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeabi|ity of the wa|ls of the blood vessels inc|uding capil|aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2O04-20O5 are more then  $1O0 milli0n USD

Further developments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny st0cks are considered highly specu|ative and may be unsuitable 
for al| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3O00 do||ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mailings, or if you feel you have been
wrongfu||y placed in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck1004 @yahoo.com      

